Achmea Investment Management B.V. Biogen Inc. Transaction History

Achmea Investment Management B.V.

$5.59 Billion
Q2 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$222.59 - $267.94 $4.84 Million - $5.82 Million	-21,733 Reduced 94.9%	1,169 $303,000
Q3 2023 Nov 06, 2023	SELL	$253.3 - $285.89 $243,421 - $274,740	-961 Reduced 4.03%	22,902 $5.89 Million
Q2 2023 Jul 24, 2023	BUY	$275.25 - $318.06 $680,693 - $786,562	2,473 Added 11.56%	23,863 $6.8 Million
Q1 2023 May 04, 2023	BUY	$256.56 - $292.34 $739,919 - $843,108	2,884 Added 15.58%	21,390 $5.95 Million
Q4 2022 Feb 09, 2023	BUY	$252.44 - $306.72 $2.41 Million - $2.92 Million	9,534 Added 106.26%	18,506 $4.8 Million
Q3 2022 Oct 27, 2022	BUY	$194.69 - $268.46 $45,168 - $62,282	232 Added 2.65%	8,972 $2.4 Million
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $49,992 - $62,988	258 Added 3.04%	8,740 $1.84 Million
Q4 2021 Feb 10, 2022	SELL	$223.92 - $287.77 $224,367 - $288,345	-1,002 Reduced 10.57%	8,482 $2.03 Million
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $429,578 - $560,217	-1,518 Reduced 13.8%	9,484 $2.68 Million
Q2 2021 Aug 06, 2021	SELL	$259.0 - $414.71 $1.94 Million - $3.11 Million	-7,495 Reduced 40.52%	11,002 $3.81 Million
Q1 2021 May 11, 2021	SELL	$242.95 - $284.63 $931,470 - $1.09 Million	-3,834 Reduced 17.17%	18,497 $5.18 Million
Q4 2020 Feb 22, 2021	SELL	$236.26 - $355.63 $3.82 Million - $5.75 Million	-16,164 Reduced 41.99%	22,331 $5.47 Million
Q3 2020 Nov 02, 2020	SELL	$264.77 - $305.71 $12.4 Million - $14.4 Million	-46,957 Reduced 54.95%	38,495 $10.9 Million
Q2 2020 Aug 12, 2020	BUY	$258.66 - $342.55 $5.05 Million - $6.69 Million	19,522 Added 29.61%	85,452 $22.9 Million
Q1 2020 May 13, 2020	BUY	$268.85 - $341.04 $12.3 Million - $15.5 Million	45,585 Added 224.06%	65,930 $20.9 Million
Q4 2019 Feb 10, 2020	SELL	$220.06 - $304.07 $2.1 Million - $2.9 Million	-9,535 Reduced 31.91%	20,345 $6.04 Million
Q3 2019 Nov 14, 2019	SELL	$217.44 - $243.88 $772,129 - $866,017	-3,551 Reduced 10.62%	29,880 $6.96 Million
Q2 2019 Aug 06, 2019	BUY	$219.29 - $241.72 $1.32 Million - $1.45 Million	6,015 Added 21.94%	33,431 $7.82 Million
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $352,587 - $551,487	1,627 Added 6.31%	27,416 $6.48 Million
Q4 2018 Feb 14, 2019	BUY	$278.5 - $352.75 $1.3 Million - $1.65 Million	4,680 Added 22.17%	25,789 $7.76 Million
Q3 2018 Nov 06, 2018	SELL	$293.51 - $383.83 $949,798 - $1.24 Million	-3,236 Reduced 13.29%	21,109 $7.45 Million
Q1 2018 May 15, 2018	SELL	$260.13 - $367.91 $274,437 - $388,145	-1,055 Reduced 4.15%	24,345 $6.66 Million
Q4 2017 Feb 12, 2018	BUY	$307.64 - $344.58 $3.17 Million - $3.55 Million	10,314 Added 68.37%	25,400 $8.09 Million
Q3 2017 Nov 09, 2017	BUY	$281.15 - $329.69 $1 Million - $1.18 Million	3,569 Added 30.99%	15,086 $4.72 Million
Q2 2017 Aug 29, 2017	BUY	N/A	11,517	11,517 $3.12 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$2.88 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.84 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.53 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.23 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$987 Million
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Achmea Investment Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Achmea Investment Management B.V. with notifications on news.

Account